Industry Growth Insights published a new data on “Pertussis Treatment Market”. The research report is titled “Pertussis Treatment Market research by Types (Azithromycin, Clarithromycin, Erythromycin, Other), By Applications (Children, Adults), By Players/Companies Sanofi, GSK, Merck, Mitsubishi Tanabe Pharma, Astellas Pharma, Shenzhen KangTai Biological Products, China National Biotec Group, Changchun Changsheng Life Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pertussis Treatment Market Research Report
By Type
Azithromycin, Clarithromycin, Erythromycin, Other
By Application
Children, Adults
By Companies
Sanofi, GSK, Merck, Mitsubishi Tanabe Pharma, Astellas Pharma, Shenzhen KangTai Biological Products, China National Biotec Group, Changchun Changsheng Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Pertussis Treatment Market Report Segments:
The global Pertussis Treatment market is segmented on the basis of:
Types
Azithromycin, Clarithromycin, Erythromycin, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- GSK
- Merck
- Mitsubishi Tanabe Pharma
- Astellas Pharma
- Shenzhen KangTai Biological Products
- China National Biotec Group
- Changchun Changsheng Life Sciences
Highlights of The Pertussis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Azithromycin
- Clarithromycin
- Erythromycin
- Other
- By Application:
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pertussis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pertussis (whooping cough) is a highly contagious respiratory illness caused by the Bordetella pertussis bacteria. Treatment typically includes antibiotics and, in some cases, oxygen therapy.
Some of the major players in the pertussis treatment market are Sanofi, GSK, Merck, Mitsubishi Tanabe Pharma, Astellas Pharma, Shenzhen KangTai Biological Products, China National Biotec Group, Changchun Changsheng Life Sciences.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pertussis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pertussis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pertussis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pertussis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pertussis Treatment Market Size & Forecast, 2018-2028
4.5.1 Pertussis Treatment Market Size and Y-o-Y Growth
4.5.2 Pertussis Treatment Market Absolute $ Opportunity
Chapter 5 Global Pertussis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pertussis Treatment Market Size Forecast by Type
5.2.1 Azithromycin
5.2.2 Clarithromycin
5.2.3 Erythromycin
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pertussis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pertussis Treatment Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pertussis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pertussis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pertussis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Pertussis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pertussis Treatment Market Size Forecast by Type
9.6.1 Azithromycin
9.6.2 Clarithromycin
9.6.3 Erythromycin
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pertussis Treatment Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pertussis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Pertussis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pertussis Treatment Market Size Forecast by Type
10.6.1 Azithromycin
10.6.2 Clarithromycin
10.6.3 Erythromycin
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pertussis Treatment Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pertussis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pertussis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pertussis Treatment Market Size Forecast by Type
11.6.1 Azithromycin
11.6.2 Clarithromycin
11.6.3 Erythromycin
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pertussis Treatment Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pertussis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Pertussis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pertussis Treatment Market Size Forecast by Type
12.6.1 Azithromycin
12.6.2 Clarithromycin
12.6.3 Erythromycin
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pertussis Treatment Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pertussis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pertussis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pertussis Treatment Market Size Forecast by Type
13.6.1 Azithromycin
13.6.2 Clarithromycin
13.6.3 Erythromycin
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pertussis Treatment Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pertussis Treatment Market: Competitive Dashboard
14.2 Global Pertussis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 GSK
14.3.3 Merck
14.3.4 Mitsubishi Tanabe Pharma
14.3.5 Astellas Pharma
14.3.6 Shenzhen KangTai Biological Products
14.3.7 China National Biotec Group
14.3.8 Changchun Changsheng Life Sciences
